Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Sensory Neurography and S2PD After Digital Nerve Injury

16. November 2026 aktualisiert von: Cecilia Mellstrand Navarro

Investigation of the Correlation of Sensory Neurography Findings and S2PD Measurements After Digital Nerve Injury

The goal of this clinical comparative cross sectional study, is to investigate neurophysiological findings and S2PD (static two point discrimination test) measurements after digital nerve injury.

The main aim is to find out if there are measurable neurophysiological differences in fingers following digital nerve injury that correlate with discriminative sensory function (S2PD) as experienced by the patient. Secondary aim is to investigate how well neurophysiological measurements predict specific S2PD values in the affected fingers.

Participants with a sutured digital nerve injury will be examined with neurophysiology and S2PD testing. Both injured finger and corresponding uninjured finger on the other hand will be examined, i.e participants will be their own control.

Prior to the study the investigators will perform a test-re-test study on ten participants to ensure that the method is reliable (separate registration)

Studienübersicht

Detaillierte Beschreibung

The aim of this project is to use neurophysiological assessment to gain a better understanding of what is actually measured by S2PD (static two-point discrimination). A neurophysiological examination can objectively measure any remaining function in an injured digital nerve. Using this method, axons responsible for pressure, vibration, and touch that are still able to conduct an action potential, are assessed.

The response can be measured both as the amplitude of the summed action potentials from the nerve's axons and as the area, which corresponds to the area under the curve formed by the recorded action potentials. The area is a somewhat more precise measurement method, as it includes all axons, both those with low and high conduction velocities. Amplitude measurements may give falsely low values if nerves with poorer degrees of myelination are included in the measurement. Amplitude is measured in µV and area in µV/ms.

The method currently used to assess discriminative sensation, S2PD, is influenced by many external factors, such as the clinician's level of experience, the patient's desire to give the correct answer, language barriers, and similar issues. Furthermore, this examination method does not clarify what is actually being measured beyond the patient's subjective discriminative sensation.

If neurophysiological assessment is used as a complement to S2PD and can provide an objective measurement tool with high reliability and reproducibility, it could become an important addition to the clinical arsenal for follow-up after nerve injury. Such knowledge would make it easier to clinically evaluate, understand, and monitor the healing process of the injured nerve. It would also facilitate the assessment and systematic follow-up of treatment outcomes.

The investigators also believe that patients would benefit from being able to follow nerve healing in a more objective manner, which could help motivate continued training and rehabilitation (such as tactile stimulation, mirror therapy, desensitization, etc.).

Participants will be identified through the national quality register for hand surgery (HAKIR), and will be invited to attend an examination at the Hand Surgery Outpatient Clinic at Sodersjukhuset by phone (postal invitation if no response). If the response rate is low, patients will be contacted by phone one additional time.

The visit, which is estimated to last approximately 60 minutes, will include assessment using static two-point discrimination (S2PD) and neurophysiological examination of the injured finger as well as the corresponding finger on the contralateral, uninjured hand. Sensory assessment with S2PD will be performed on the fingertip pulp, radially or ulnarly, using a discriminator. Sensory thresholds, measured in millimetres, will be recorded in the study protocol.

Finger temperature will be measured using an infrared thermometer (Testo 826-T2), and, if necessary, the fingers will be warmed (using a water bath or heating pad) to a target temperature of a minimum of 32 °C. The hands will then be gently abraded using a preparation gel (NuPrep). Conductive gel (Ten20) will be applied to the electrodes.

A recording electrode will be placed volarly over the wrist, a ground electrode in the palm, and a stimulating electrode on the finger (digits II, III, or IV). Electrical stimulation will be delivered in an orthodromic direction, from the finger toward the wrist. The stimulus intensity will be gradually increased as long as the recorded amplitude continues to rise, up to a maximum of 20% above the intensity at which no further increase in amplitude is observed. This approach ensures inclusion of all excitable axons in the recording, regardless of individual firing thresholds.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

60

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

    • Stockholm County
      • Stockholm, Stockholm County, Schweden, 11883
        • Noch keine Rekrutierung
        • Karolinska Institutet Södersjukhuset, Department of clinical research and education

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

20 Jahre bis 60 Jahre (Erwachsene)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Patients treated surgically for a digital nerve injury at the Sodersjukhuset Hand Surgery Clinic from 2013 to 2023.

Beschreibung

Inclusion Criteria:

  • Injury: One year or more prior to inclusion
  • Injured finger: digit II, III or radial dig IV
  • Level of injury: base or middle phalanx
  • Age at injury>20
  • Age at inclusion<60

Exclusion Criteria:

  • Neurologic disease
  • Dementia
  • Cognitive disability
  • Severe psychiatric disorder (not be able to participate)
  • Ongoing drug abuse
  • Not understanding swedish language
  • History of ongoing carpal tunnel syndrome
  • Negative experience of electric stimulation

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: CASE_CONTROL
  • Zeitperspektiven: CROSS_SECTIONAL

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Sensory and neurophysiology outcome in injured digit

The finger with an injured digital nerve will be examined with S2PD and sensory neurography

Participants will be examined with sensory neurography (orthodromic stimulation).

Participants will be examined with S2PD.

Sensory and neurophysiology outcome in normal digit

The contralateral uninjured finger will be examined with S2PD and sensory neurography

Participants will be examined with sensory neurography (orthodromic stimulation).

Participants will be examined with S2PD.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Is there a correlation between the amplitude of the sensory nerve action potential and S2PD?
Zeitfenster: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A potential correlation between the sensory nerve action potential amplitude (microvoltage) measured with sensory neurography and S2PD (in millimeters) measured with a discriminator, will be analysed with test for correlation and presented as a value between -1 and 1

Participant assessments will be conducted during a single session lasting approximately 60 minutes
Is there a correlation between sensory nerve action potential area and S2PD?
Zeitfenster: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A potential correlation between the sensory nerve action potential area (milliseconds*microvoltage) measured with sensory neurography and S2PD (in millimeters) measured with a discriminator, will be analysed with test for correlation and presented as a value between -1 and 1

Participant assessments will be conducted during a single session lasting approximately 60 minutes

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Does a certain value of S2PD correspond to a specific (percentage) value of the amplitude or area of the action potential?
Zeitfenster: Participant assessments will be conducted during a single session lasting approximately 60 minutes

We will evaluate the correlation between S2PD (in 1 mm steps) and the percentages of sensory neurography amplitude and area of the injured nerve.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does age affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Zeitfenster: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact age (years) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does participants' sex affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Zeitfenster: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact participants' sex (male or female) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does smoking affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Zeitfenster: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact smoking (yes or no) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does the type of injured nerve affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Zeitfenster: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact type of injured nerve (digital nerves to second, third or radial side of the fourth finger) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does time from injury affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Zeitfenster: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact time from injury (in years) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does the level of injury affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Zeitfenster: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact level of injury (proximal or middle phalanx) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Cecilia Mellstrand-Navarro, Ass. prof, Karolinska Institutet Södersjukhuset, Department of clinical research and education

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

28. September 2026

Primärer Abschluss (Geschätzt)

31. Dezember 2026

Studienabschluss (Geschätzt)

31. Dezember 2026

Studienanmeldedaten

Zuerst eingereicht

9. Oktober 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

23. Oktober 2026

Zuerst gepostet (Tatsächlich)

29. Oktober 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

17. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

16. November 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2023-05732-01
  • 2023 (US NIH Stipendium/Vertrag)

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Data will be available in pseudonymized form

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren